# Feng Shen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/feng-shen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,561 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 70 |
| i10-index | 262 |
| Last Known Institution | Qingdao University |
| OpenAlex ID | https://openalex.org/A5042624998 |
| ORCID iD | https://orcid.org/0000-0002-8904-9745 |
| Works | 468 |

## Researcher papers

- [Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)](https://scholariq.org/papers/guidelines-for-the-diagnosis-and-treatment-of-hepatocellular-carcinoma-2019/)
- [Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)](https://scholariq.org/papers/guidelines-for-diagnosis-and-treatment-of-primary-liver-cancer-in-china-2017/)
- [Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus–Related Hepatocellular Carcinoma Within the Milan Criteria](https://scholariq.org/papers/nomogram-for-preoperative-estimation-of-microvascular-invasion-risk-in-hepatitis/)
- [Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)](https://scholariq.org/papers/guidelines-for-the-diagnosis-and-treatment-of-primary-liver-cancer-2022-edition/)
- [Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection](https://scholariq.org/papers/management-and-outcomes-of-patients-with-recurrent-intrahepatic/)
- [Early <i>versus</i> late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent](https://scholariq.org/papers/early-i-versus-i-late-recurrence-of-intrahepatic-cholangiocarcinoma-after/)
- [High Serum Levels of Cholesterol Increase Antitumor Functions of Nature Killer Cells and Reduce Growth of Liver Tumors in Mice](https://scholariq.org/papers/high-serum-levels-of-cholesterol-increase-antitumor-functions-of-nature-killer/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Gallbladder and Bile Duct Disorders](https://scholariq.org/topics/gallbladder-and-bile-duct-disorders/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)

## Researcher university

- [Qingdao University](https://scholariq.org/institutions/qingdao-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.